Federal Register #DEA-1691

DEA Solicitation: Manufacture and Import of Schedule I Controlled Substances for Research and Reference Standards

The Drug Enforcement Administration (DEA), part of the Justice Department, is announcing applications from several organizations to manufacture or import Schedule I controlled substances for research and reference standard purposes. - Government Buyer: - Drug Enforcement Administration (DEA), Justice Department - OEMs and Vendors Mentioned: - Chemtos, LLC (bulk manufacturer) - Usona Institute (importer) - Pharmaron Manufacturing Services (US) LLC (importer) - Products/Services Requested: - Bulk manufacture of Schedule I controlled substances by Chemtos, LLC for distribution as reference standards - Substances include: 4-Chloromethcathinone, 1-(4-methoxyphenyl)-N-methylpropan-2-amine, 4,4-Dimethylaminorex, 4F-MDMB-BINACA, MDMB-4en-PINACA, methoxetamine, Alpha-Pyrrolidinoheptaphenone (PV8), Butonitazene, Flunitazene, Metonitazene, N-Pyrrolidino etonitazene, Protonitazene, N-pyrrolidino metonitazene, N-pyrrolidino protonitazene, Metodesnitazene, Etodesnitazene (etazene), and other synthetic compounds - Import of Schedule I controlled substances by Usona Institute for research and analytical purposes only - Substances include: Mescaline, 5-Methoxy-N-N-dimethyltryptamine, Dimethyltryptamine, Psilocybin, Psilocyn - Import of Schedule I controlled substances by Pharmaron Manufacturing Services (US) LLC - Unique or Notable Requirements: - All activities are strictly limited to manufacturing or importing for research, analytical, or reference standard use - No clinical or human consumption activities are authorized - DEA is accepting public comments and objections regarding these applications - Locations: - Chemtos, LLC: 16713 Picadilly Court, Round Rock, Texas - Usona Institute: 2780 Woods Hollow Road, Fitchburg, Wisconsin - DEA Contracting Office: 8701 Morrissette Drive, Springfield, Virginia

Description

Chemtos, LLC has applied to be registered as a bulk manufacturer of various basic classes of controlled substances, including Schedule I drugs such as 4-Chloromethcathinone and several others. The company plans to manufacture these substances in bulk for distribution as reference standards to its customers. Comments on this application can be submitted electronically until May 29, 2026. No other activities besides bulk manufacturing for reference standards are authorized under this registration.

View original listing